XML 43 R31.htm IDEA: XBRL DOCUMENT v3.22.4
Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance
A summary of the company’s interest rate swaps is as follows (in thousands):
  Twelve Months Ended
 LocationDec 31, 2022Jan 1, 2022
Fair valuePrepaid expenses$6,805 $— 
Fair valueOther assets$58,180 $3,645 
Fair valueAccrued expenses$— $1,171 
Fair valueOther non-current liabilities$— $20,464 
Amount of gain/(loss) recognized in other comprehensive incomeOther comprehensive income$79,472 $14,634 
Gain/(loss) reclassified from accumulated other comprehensive income (effective portion)Interest expense$(3,503)$(18,469)